GO:0070186 growth hormone activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070186 growth hormone activity describes the molecular function of growth hormone (GH), a peptide hormone secreted by the anterior pituitary or placenta that binds membrane receptors in target tissues to stimulate body growth.
• GH activity is not a single gene product but the action characteristic of the GH peptide, encoded primarily by GH1 (pituitary) and GH2 (placental), acting through the GH receptor (GHR).
• GH exerts its effects both directly and indirectly, notably by stimulating insulin-like growth factor 1 (IGF1) production in the liver, which mediates many growth-promoting actions.
• Exercise is a potent physiological stimulus of GH secretion, with resistance training, aerobic exercise, and stress-related endocrine responses all modulating circulating GH levels.
• GH activity is central to muscle hypertrophy, body composition, and metabolic regulation, making it a key target in sports science, endocrinology, and metabolic disease research.
• Studying GO:0070186 requires integrated approaches including CRISPR knockout/knock-in models, hormone assays, and transcriptomic/proteomic readouts to link GH signaling to downstream growth programs.
Description
Growth hormone activity (GO:0070186) is a molecular function term that captures the biological action of growth hormone (GH), a peptide hormone secreted by the anterior pituitary or the placenta into the circulation. GH binds to membrane receptors in target tissues and initiates signaling cascades that stimulate body growth, making this GO term a central node in endocrine, metabolic, and musculoskeletal research. Understanding GH activity is essential for interpreting how the body integrates hormonal signals with growth, exercise, and stress responses. At the molecular level, GH activity is defined by the characteristic action of the GH peptide rather than by a single catalytic reaction. The hormone is encoded by GH1 in the pituitary and GH2 in the placenta, and its actions are mediated through the GH receptor (GHR) and downstream effectors including insulin-like growth factor 1 (IGF1). This functional annotation is therefore used to describe the hormone's receptor-binding and growth-promoting roles across species and experimental systems. For researchers, GO:0070186 provides a standardized way to annotate genes, proteins, and pathways linked to GH biology. It is particularly relevant in studies of exercise endocrinology, where GH secretion is acutely modulated by training variables such as rest interval, intensity, and modality. The term also connects to broader questions about muscle hypertrophy, metabolic health, and endocrine disorders, as reviewed in recent evidence-guided syntheses.
growth hormone activity At A Glance
| GO ID | GO:0070186 |
|---|---|
| GO term | growth hormone activity |
| Ontology | molecular_function |
| Synonym | GH activity; pituitary growth hormone activity; placental growth hormone activity |
| Major function | Peptide hormone action that binds membrane receptors in target tissues to stimulate body growth |
| Source | Secreted by the anterior pituitary or the placenta into the circulation |
| Target | Membrane receptors in target tissues |
| Biological outcome | Stimulation of body growth and related metabolic and anabolic processes |
| Related hormones | Growth hormone, insulin-like growth factor 1 (IGF1), and interacting endocrine factors |
What Is GO:0070186?
GO:0070186 growth hormone activity is defined as the action characteristic of growth hormone, a peptide hormone that is secreted by the anterior pituitary or the placenta into the circulation, and binds to membrane receptors in target tissues to stimulate body growth. In practical terms, this molecular function describes the hormone's ability to act as a circulating signal that engages specific receptors and triggers growth-related cellular responses.
Why Is growth hormone activity Important in Cell Biology?
GO:0070186 growth hormone activity is important because it provides a precise functional annotation for one of the most pleiotropic endocrine signals in vertebrates. GH governs somatic growth, muscle protein synthesis, lipolysis, and glucose metabolism, and its secretion is dynamically regulated by exercise, stress, nutrition, and sleep. In research, this term helps link genetic and pharmacological manipulations to a defined molecular function, enabling reproducible comparisons across cell models, animal studies, and human trials. It is also a key reference point for understanding how endocrine signals integrate with training adaptations and metabolic disease risk.
• GH activity is a master regulator of postnatal body growth and skeletal muscle hypertrophy.
• It mediates anabolic effects on protein synthesis and lean mass, relevant to exercise science and rehabilitation.
• GH stimulates hepatic and local IGF1 production, which amplifies growth-promoting signals in target tissues.
• Exercise-induced GH secretion is influenced by training variables such as rest interval, intensity, and modality.
• GH activity is studied in endocrine disorders including GH deficiency and acromegaly, where signaling is dysregulated.
• It contributes to metabolic regulation, including lipolysis and insulin sensitivity, linking it to obesity and diabetes research.
• Stress system activation modulates GH release, connecting this GO term to neuroendocrine research.
• Detraining and insufficient training stimulus can reverse training-induced endocrine and performance adaptations, highlighting GH's role in adaptation.
• Ergogenic aid research has historically examined GH as a performance-enhancing hormone, underscoring its physiological potency.
• Arginine and other nutritional factors can modulate GH secretion, making this term relevant to nutraceutical and sports nutrition studies.
Molecular Mechanism of growth hormone activity
Hormone synthesis and secretion
In simple terms: Growth hormone is made and released by the pituitary gland or placenta into the blood.
GH is a peptide hormone secreted by the anterior pituitary or the placenta into the circulation. Its secretion is pulsatile and influenced by physiological states including exercise, stress, sleep, and nutritional status. The hormone is encoded by GH1 in the pituitary and GH2 in the placenta, and these genes give rise to the circulating peptide that carries GH activity.
Receptor binding at target tissues
In simple terms: GH travels in the blood and docks onto specific receptors on target cells.
The defining action of GO:0070186 is the binding of GH to membrane receptors in target tissues. This receptor engagement initiates intracellular signaling that ultimately stimulates body growth and related anabolic processes. The GH receptor (GHR) is the principal mediator of these effects, and its activation is a prerequisite for downstream growth-promoting responses.
IGF1 induction and endocrine amplification
In simple terms: GH tells the liver and other tissues to make IGF1, which then drives growth.
A major mechanism by which GH activity promotes growth is through stimulation of insulin-like growth factor 1 (IGF1) production, particularly in the liver. IGF1 then acts on target tissues to mediate many of the growth-promoting effects attributed to GH. This endocrine axis integrates GH activity with broader growth and metabolic programs.
Exercise and stress modulation of GH activity
In simple terms: Exercise and stress change how much GH is released and how it acts.
Exercise is a potent stimulus for GH secretion, and the magnitude of the response depends on training variables such as rest interval, intensity, and exercise type. Stress system activation also modulates GH release, linking this molecular function to neuroendocrine integration. Resistance training and aerobic exercise can both influence circulating GH, although the exact patterns depend on the protocol.
Downstream anabolic and metabolic effects
In simple terms: GH activity helps build muscle and influences how the body uses fat and sugar.
GH activity contributes to muscle hypertrophy and body composition through anabolic effects on protein metabolism. It also influences lipolysis and glucose metabolism, which are relevant to metabolic health and disease. These downstream effects are mediated by receptor signaling and by IGF1-dependent and IGF1-independent pathways.
Key Genes Involved in GO:0070186 growth hormone activity
The following genes and proteins are central to growth hormone activity (GO:0070186) and are commonly studied in endocrine, exercise, and metabolic research.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GH1 | Encodes pituitary growth hormone | Primary source of circulating GH; target for KO and knock-in models |
| GH2 | Encodes placental growth hormone | Placental GH activity; relevant to pregnancy and fetal growth studies |
| GHR | Growth hormone receptor | Mediates GH binding and signaling; key for receptor knockout and point-mutation studies |
| IGF1 | Insulin-like growth factor 1 | Mediates many GH growth-promoting effects; downstream readout |
| IGF1R | IGF1 receptor | Transduces IGF1 signals; relevant to growth and hypertrophy research |
| JAK2 | Janus kinase 2 | Tyrosine kinase activated by GHR; central to GH signaling |
| STAT5A | Signal transducer and activator of transcription 5A | Transcription factor downstream of GHR; regulates IGF1 and growth genes |
| STAT5B | Signal transducer and activator of transcription 5B | Key mediator of GH-dependent gene expression and growth |
| SOCS2 | Suppressor of cytokine signaling 2 | Negative regulator of GH signaling; modulates growth |
| POU1F1 | Pituitary-specific transcription factor 1 | Regulates GH1 expression and pituitary development |
| PROP1 | PROP paired-like homeobox 1 | Required for pituitary development and GH-producing cell differentiation |
| GHRH | Growth hormone-releasing hormone | Stimulates GH secretion from the pituitary |
| GHSR | Growth hormone secretagogue receptor | Mediates ghrelin-stimulated GH release |
| SST | Somatostatin | Inhibits GH secretion; negative regulator of GH activity |
| NPY | Neuropeptide Y | Modulates hypothalamic control of GH secretion |
| LEPR | Leptin receptor | Links energy status to GH secretion and activity |
| INS | Insulin | Interacts with GH/IGF1 axis in metabolic regulation |
| FOXO1 | Forkhead box O1 | Transcription factor integrating GH/IGF1 signals with metabolism |
How Is growth hormone activity Regulated?
Growth hormone activity is regulated at multiple levels, including hypothalamic control of GH secretion, feedback by IGF1, and peripheral modulation by nutritional and stress signals. GHRH stimulates and somatostatin inhibits GH release from the pituitary, while ghrelin via GHSR provides an additional stimulatory input. Exercise and stress can acutely increase circulating GH, and the magnitude of this response depends on training variables such as rest interval and exercise type. Negative regulators such as SOCS2 attenuate GH signaling, and detraining can reverse training-induced endocrine adaptations. Nutritional factors, including arginine, can also modulate GH secretion, linking this GO term to sports nutrition research.
growth hormone activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GH1 | Growth hormone deficiency | GH1 knockout cell line or knock-in of patient variants |
| GHR | Laron syndrome / GH insensitivity | GHR knockout or point-mutation cell models |
| STAT5B | GH insensitivity and immune dysregulation | STAT5B knockout and rescue overexpression |
| IGF1 | Growth failure and metabolic dysfunction | IGF1 knockout or tagged knock-in for localization |
| POU1F1 | Combined pituitary hormone deficiency | POU1F1 knockout pituitary cell models |
Growth hormone deficiency and short stature
Impaired GH activity can lead to growth hormone deficiency, a condition characterized by short stature and altered body composition. Genetic defects in GH1, GHRHR, or pituitary transcription factors such as POU1F1 and PROP1 can reduce GH production or action. Research models using knockout and knock-in approaches help dissect the contribution of specific genes to GH activity and growth outcomes.
Acromegaly and GH excess
Excessive GH activity, most commonly due to pituitary adenomas, causes acromegaly, a disorder marked by abnormal growth of bones and soft tissues. Studying GH receptor signaling and downstream effectors such as JAK2 and STAT5B is central to understanding disease mechanisms. Cell and animal models with altered GH activity are valuable for testing therapeutic strategies.
Metabolic disorders and body composition
GH activity influences lipolysis, glucose metabolism, and insulin sensitivity, making it relevant to obesity, metabolic syndrome, and diabetes research. The interplay between GH, IGF1, and insulin is a key area of endocrine investigation. Exercise and nutritional interventions that modulate GH secretion are studied for their metabolic effects.
Muscle hypertrophy and exercise adaptation
GH activity is implicated in exercise-induced muscle hypertrophy, although its precise contribution relative to other hormones remains debated. Resistance training and rest interval manipulation can acutely alter GH secretion, which has implications for training program design. Detraining studies show that loss of training stimulus can reverse endocrine and performance adaptations, highlighting the dynamic nature of GH-related responses.
From growth hormone activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of GH1 abolish GH activity in pituitary cells? | GH1 knockout cell line |
| Does a specific GHR variant alter receptor signaling? | GHR point-mutation knock-in |
| Where is GH1 expressed and secreted? | Tagged knock-in of GH1 with fluorescent or epitope tag |
| Does overexpression of GH increase IGF1 production? | GH overexpression cell model |
| Which genes mediate GH-dependent growth? | CRISPR library screening in GH-responsive cells |
| How does GH activity change with exercise mimetics? | In vitro exercise model with GH treatment and transcriptomics |
How to Study the growth hormone activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ELISA/immunoassay | GH and IGF1 protein levels | Quantifying hormone secretion in cell culture or serum |
| RNA-seq | Transcriptional changes | Identifying GH-regulated genes and pathways |
| Proteomics | Protein expression and modifications | Mapping signaling downstream of GHR |
| CRISPR knockout | Loss-of-function effects | Testing necessity of GH1, GHR, or STAT5B |
| CRISPR knock-in | Precise allele replacement | Modeling patient variants or tagging endogenous loci |
| Overexpression | Gain-of-function effects | Testing sufficiency of GH or IGF1 in growth assays |
| CRISPR library screening | Genome-wide modifier identification | Discovering regulators of GH activity |
Hormone quantification assays
Measuring GH levels in circulation or conditioned medium is a direct way to assess growth hormone activity. Immunoassays and mass spectrometry-based methods can quantify GH and IGF1, providing readouts for endocrine studies. These methods are essential for validating knockout or overexpression models.
Transcriptomic and proteomic profiling
RNA sequencing and proteomics can identify downstream targets of GH activity, including IGF1 and STAT5-dependent genes. Comparing wild-type and GH-pathway mutant cells reveals the gene expression programs controlled by this molecular function. Such datasets are valuable for building regulatory networks around GO:0070186.
CRISPR-based functional genomics
CRISPR knockout, knock-in, and point-mutation models allow precise dissection of genes involved in GH activity. Library screening can identify modifiers of GH signaling and growth responses. These approaches are increasingly used in endocrine and metabolic research.
Exercise and stress challenge studies
Human and animal exercise studies can assess how training variables such as rest interval and intensity affect GH secretion. Stress system activation and detraining paradigms further reveal the plasticity of GH responses. These studies link molecular function to whole-body physiology.
How CRISPR Can Be Used to Study GO:0070186 growth hormone activity
Knockout
CRISPR knockout of GH1, GHR, or downstream signaling genes can abolish or reduce growth hormone activity in cell models. These models are used to test whether a candidate gene is required for GH-dependent growth and metabolic responses. Knockout studies also help validate antibody specificity and pathway dependencies.
Point Mutation
Point-mutation knock-in can model naturally occurring variants in GH1 or GHR that alter hormone activity or receptor function. Such models are valuable for understanding genotype-phenotype relationships in growth disorders. They also allow precise structure-function studies of the GH-receptor interaction.
Knock-in
Tagged knock-in of GH1 or GHR with fluorescent or epitope tags enables real-time tracking of hormone expression and localization. Knock-in of reporter cassettes can create sensitive readouts for GH pathway activity. These models are useful for imaging and biochemical studies.
Overexpression
Overexpression of GH or IGF1 in cell models can test sufficiency for growth-promoting phenotypes. Such models are used to study downstream signaling and metabolic effects. They complement loss-of-function approaches for a complete picture of GH activity.
How EDITGENE Supports growth hormone activity Research
Researchers studying growth hormone activity-related genes often need to determine whether a candidate gene is causally involved in GH signaling, growth, or metabolic regulation. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models for such investigations, from knockout to knock-in and library screening.
Contact EDITGENE today to design your custom CRISPR model for growth hormone activity research.
Frequently Asked Questions About growth hormone activity
What is growth hormone activity GO:0070186?
GO:0070186 growth hormone activity is a molecular function term describing the action of growth hormone, a peptide hormone secreted by the anterior pituitary or placenta that binds membrane receptors in target tissues to stimulate body growth.
What genes are involved in growth hormone activity?
Key genes include GH1, GH2, GHR, IGF1, JAK2, STAT5A, STAT5B, and SOCS2, among others.
How is growth hormone activity regulated?
It is regulated by hypothalamic GHRH and somatostatin, feedback by IGF1, and peripheral factors such as exercise, stress, and nutrition.
Does exercise increase growth hormone activity?
Exercise is a potent stimulus for GH secretion, and the response depends on training variables such as rest interval, intensity, and modality.
What diseases are linked to growth hormone activity?
Disorders include growth hormone deficiency, acromegaly, Laron syndrome, and metabolic conditions such as obesity and diabetes.
How can I study growth hormone activity in the lab?
Common methods include hormone assays, RNA-seq, proteomics, and CRISPR knockout or knock-in models targeting GH pathway genes.
What is the role of IGF1 in growth hormone activity?
IGF1 is induced by GH and mediates many of its growth-promoting effects in target tissues.
Can CRISPR be used to model growth hormone disorders?
Yes, CRISPR knockout, knock-in, and point-mutation models can recapitulate genetic defects in GH1, GHR, and downstream signaling genes.
What is the difference between GH1 and GH2?
GH1 encodes pituitary growth hormone, while GH2 encodes placental growth hormone; both contribute to growth hormone activity.
Why is growth hormone activity important for muscle hypertrophy?
GH activity contributes to anabolic processes and muscle growth, although its precise role relative to other hormones is still studied.
Conclusion
GO:0070186 growth hormone activity provides a standardized molecular function annotation for the action of GH, a peptide hormone central to growth, metabolism, and exercise adaptation. Understanding its mechanisms, key genes, and regulatory inputs is essential for researchers in endocrinology, sports science, and metabolic disease. CRISPR-based models offer powerful tools to dissect this pathway and identify new therapeutic targets. By integrating precise gene editing with functional assays, studies of growth hormone activity can move from correlation to causation, ultimately informing interventions for growth disorders and metabolic health.
References
- 1. de Salles BF et al.. 2009. Rest interval between sets in strength training.. Sports Med 39(9):765-77 PMID: 19691365
- 2. Kraemer WJ et al.. 2020. Growth Hormone(s), Testosterone, Insulin-Like Growth Factors, and Cortisol: Roles and Integration for Cellular Development and Growth With Exercise.. Front Endocrinol (Lausanne) 11:33 PMID: 32158429
- 3. Athanasiou N et al.. 2023. Endocrine responses of the stress system to different types of exercise.. Rev Endocr Metab Disord 24(2):251-266 PMID: 36242699
- 4. Thein LA et al.. 1995. Ergogenic aids.. Phys Ther 75(5):426-39 PMID: 7732086
- 5. Mujika I et al.. 2000. Detraining: loss of training-induced physiological and performance adaptations. Part I: short term insufficient training stimulus.. Sports Med 30(2):79-87 PMID: 10966148
- 6. Van Every DW et al.. 2024. Hormones, Hypertrophy, and Hype: An Evidence-Guided Primer on Endogenous Endocrine Influences on Exercise-Induced Muscle Hypertrophy.. Exerc Sport Sci Rev 52(4):117-125 PMID: 39190607
- 7. Kanaley JA. 2008. Growth hormone, arginine and exercise.. Curr Opin Clin Nutr Metab Care 11(1):50-4 PMID: 18090659
- 8. Jenkins PJ. 1999. Growth hormone and exercise.. Clin Endocrinol (Oxf) 50(6):683-9 PMID: 10468938
